The Journal of Pediatrics
Volume 153, Issue 1 , Pages 117-121.e3, July 2008

Resistance to Intravenous Immunoglobulin in Children with Kawasaki Disease

  • Adriana H. Tremoulet, MD

      Affiliations

    • Department of Pediatrics, University of California San Diego School of Medicine and Rady Children's Hospital San Diego, San Diego, CA
  • ,
  • Brookie M. Best, PharmD

      Affiliations

    • Department of Pediatrics, University of California San Diego School of Medicine and Rady Children's Hospital San Diego, San Diego, CA
    • Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA
  • ,
  • Sungchan Song, BS

      Affiliations

    • Department of Pediatrics, University of California San Diego School of Medicine and Rady Children's Hospital San Diego, San Diego, CA
  • ,
  • Susan Wang

      Affiliations

    • Department of Pediatrics, University of California San Diego School of Medicine and Rady Children's Hospital San Diego, San Diego, CA
  • ,
  • Elena Corinaldesi, MD

      Affiliations

    • Department of Pediatrics, University of California San Diego School of Medicine and Rady Children's Hospital San Diego, San Diego, CA
  • ,
  • Julia R. Eichenfield

      Affiliations

    • Department of Pediatrics, University of California San Diego School of Medicine and Rady Children's Hospital San Diego, San Diego, CA
  • ,
  • Danielle D. Martin, BS

      Affiliations

    • Department of Cardiology, Children's Hospital Boston, Boston, MA.
  • ,
  • Jane W. Newburger, MD, MPH

      Affiliations

    • Department of Cardiology, Children's Hospital Boston, Boston, MA.
  • ,
  • Jane C. Burns, MD

      Affiliations

    • Department of Pediatrics, University of California San Diego School of Medicine and Rady Children's Hospital San Diego, San Diego, CA

Received 4 July 2007; received in revised form 22 October 2007; accepted 10 December 2007. published online 25 February 2008.

Objectives

To explore the increased incidence of intravenous immunoglobulin- (IVIG) resistance among San Diego County patients with Kawasaki disease (KD) in 2006 and to evaluate a scoring system to predict IVIG-resistant patients with KD.

Study design

We performed a retrospective review of patients with KD treated within 10 days of fever onset. With multivariate analysis, independent predictors of IVIG-resistance were combined into a scoring system.

Results

In 2006, 38.3% of patients with KD in San Diego County were IVIG-resistant, a significant increase over previous years. IVIG-resistance was not associated with a particular brand or lot of IVIG. Resistant patients were diagnosed earlier, had higher percent bands, and higher concentrations of C-reactive protein, alanine aminotransferase, and γ-glutamyl transferase. They also had lower platelet counts and age-adjusted hemoglobin concentrations and were more likely to have aneurysms (P = .0008). A scoring system developed to predict IVIG-resistant patients using illness day, percent bands, γ-glutamyl transferase, and age-adjusted hemoglobin had a sensitivity of 73.3% and specificity of 61.9%.

Conclusions

An unexplained increase in IVIG-resistance was noted among patients with KD in San Diego County in 2006. Scoring systems based on demographic and laboratory data were insufficiently accurate to be clinically useful in our ethnically diverse population.

Abbreviations: ALT, Alanine aminotransferase, CRP, C-reactive protein, ESR, Erythrocyte sedimentation rate, GGT, γ-Glutamyl transferase, IVIG, Intravenous immunoglobulin, KD, Kawasaki disease, zHgb, Age-adjusted hemoglobin

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by grants from the National Heart, Lung, and Blood Institute (HL69413 and K24 HL074864), from the National Institute for Child Health and Human Development, Pediatric Pharmacology Research Unit (5U10 HD031318), and the Ciaranello Family Fund at Children's Hospital Boston.

 No reprints available.

PII: S0022-3476(07)01167-5

doi:10.1016/j.jpeds.2007.12.021

The Journal of Pediatrics
Volume 153, Issue 1 , Pages 117-121.e3, July 2008